Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverNEPH
HealthcareNCMUSD

Nephros, Inc.

$00123456789.0012345678900123456789-1.1%
52w low $2.66$6.42 52w high
Market data · updated 1h ago
Market data
Market cap
$36.80M
52w range
$2.66 - $6.42
Beta
1.49
Sector
Healthcare
Data quality
96/100
Valuation
P/E ratio
48.4x
fair value estimate
$1.36
Margin of safety
-62.9%
Forward P/E
23.4x
Quality & efficiency
Moat score
47/100
Return on equity
7.8%
Profit margin
4.1%
Debt / equity
0.09
Growth & analysts
Revenue growth
+6.9%
Analyst target
$6.00
Target upside
+63.5%
Analysts
3
Run the 10-point checklist before you buy How these numbers are made

About Nephros, Inc.

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Valuation

ValueGrowthProfitHealthIncome29QUALITY
Overall Rating
26
Very low quality
Very low quality

Derived from filed metrics · High confidence (96% of the inputs available)

Moat Score47
Fair value estimate
$1.36-62.9% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$36.80M
P/E Ratio
48.4
Dividend Yield
0.00%
Revenue Growth
+6.9%
Profit Margin
4.1%
ROE
7.8%
Debt / Equity
0.09
Beta
1.49
Beaten Down

Statistics

Similar Stocks · Healthcare

Latest News · NEPH